-
2
-
-
84867857009
-
-
Chinese source
-
2010, 09: 193-195.
-
(2010)
, vol.9
, pp. 193-195
-
-
-
3
-
-
79958084506
-
MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas
-
Butz H, Likó I, Czirják S, et al. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas. Pituitary, 2011, 14: 112-124.
-
(2011)
Pituitary
, vol.14
, pp. 112-124
-
-
Butz, H.1
Likó, I.2
Czirják, S.3
-
4
-
-
18844459384
-
miR-15a and miR-16-1 down-regulation in pituitary adenomas
-
Bottom A, Piccin D, Tagliati F, et al. miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol, 2005, 204: 280-285.
-
(2005)
J Cell Physiol
, vol.204
, pp. 280-285
-
-
Bottom, A.1
Piccin, D.2
Tagliati, F.3
-
5
-
-
33845608588
-
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas
-
Bottom A, Zatelli M C, Ferracin M, et al. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol, 2007, 210: 370-377.
-
(2007)
J Cell Physiol
, vol.210
, pp. 370-377
-
-
Bottom, A.1
Zatelli, M.C.2
Ferracin, M.3
-
6
-
-
38649116343
-
Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion
-
Wu Z B, Su Z P, Wu J S, et al. Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion. Pituitary, 2008, 11: 63-70.
-
(2008)
Pituitary
, vol.11
, pp. 63-70
-
-
Wu, Z.B.1
Su, Z.P.2
Wu, J.S.3
-
7
-
-
77953178125
-
Mucin 1 oncoprotein expression is suppressed by the miR-125β oncomir
-
Rajabi H, Jin C, Ahmad R, et al. Mucin 1 Oncoprotein Expression Is Suppressed by the miR-125β Oncomir. Genes Cancer, 2010, 1: 62-68.
-
(2010)
Genes Cancer
, vol.1
, pp. 62-68
-
-
Rajabi, H.1
Jin, C.2
Ahmad, R.3
-
8
-
-
79951972107
-
MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3
-
Huang L, Luo J, Cai Q, et al. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int J Cancer, 2011, 128: 1758-1769.
-
(2011)
Int J Cancer
, vol.128
, pp. 1758-1769
-
-
Huang, L.1
Luo, J.2
Cai, Q.3
-
9
-
-
69349087756
-
miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy
-
Adam L, Zhong M, Choi W, et al. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res, 2009, 15: 5060-5072.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5060-5072
-
-
Adam, L.1
Zhong, M.2
Choi, W.3
-
10
-
-
77951248184
-
E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells
-
Tryndyak V P, Beland F A, Pogribny I P. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Nt J Cancer, 2010, 126: 2575-2583.
-
(2010)
Nt J Cancer
, vol.126
, pp. 2575-2583
-
-
Tryndyak, V.P.1
Beland, F.A.2
Pogribny, I.P.3
-
11
-
-
77949873402
-
Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma
-
Chao A, Tsai C L, Wei P C, et al. Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma. Cancer Lett, 2010, 291: 99-107.
-
(2010)
Cancer Lett
, vol.291
, pp. 99-107
-
-
Chao, A.1
Tsai, C.L.2
Wei, P.C.3
-
12
-
-
14844364472
-
Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis
-
Cheng A M, Byrom M W, Shelton J, et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res, 2005, 33: 1290-1297.
-
(2005)
Nucleic Acids Res
, vol.33
, pp. 1290-1297
-
-
Cheng, A.M.1
Byrom, M.W.2
Shelton, J.3
|